Published in Front Immunol on November 10, 2016
Chagas disease. Lancet (2010) 10.25
Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol (1999) 5.86
The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20
Trypanosoma cruzi: modification of macrophage function during infection. J Exp Med (1977) 2.69
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 2.18
Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol (1991) 2.08
Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun (1996) 1.93
uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol (2004) 1.71
The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol (2005) 1.60
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci (2007) 1.49
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther (2010) 1.46
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood (2008) 1.45
Ontogeny of early life immunity. Trends Immunol (2014) 1.35
Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol (1988) 1.18
Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun (2005) 1.17
A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J (1997) 1.17
NKT cell networks in the regulation of tumor immunity. Front Immunol (2014) 1.13
Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin Exp Immunol (1997) 1.08
Involvement of urokinase-type plasminogen activator system in cancer: an overview. Med Res Rev (2014) 1.06
The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun (1999) 1.05
Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun (2006) 1.02
The human neonatal gut microbiome: a brief review. Front Pediatr (2015) 1.01
IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol Lett (2000) 0.99
Soluble mediators regulating immunity in early life. Front Immunol (2014) 0.99
Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol (2001) 0.97
Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease. Mol Cell Proteomics (2012) 0.97
The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol (1995) 0.96
Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target. Enzyme Res (2011) 0.95
NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect Immun (2004) 0.94
Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ. Front Immunol (2013) 0.94
Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes. J Immunol (2002) 0.93
NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol (2002) 0.93
Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages. Med Microbiol Immunol (1996) 0.92
Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect Immun (2005) 0.90
Diverse functions of distal regulatory elements at the IFNG locus. J Immunol (2012) 0.89
Chagas' Disease. N Engl J Med (2015) 0.88
Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi. Clin Exp Immunol (2000) 0.86
Inhibitory receptors specific for MHC class I educate murine NK cells but not CD8αα intestinal intraepithelial T lymphocytes. Blood (2011) 0.86
Chagas' disease: decreased resistance to Trypanosoma cruzi acquired infection in offspring of infected mice. Am J Trop Med Hyg (1992) 0.84
NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Int Immunol (2005) 0.84
Abundant stage-dependent Ly49E expression by liver NK cells is not essential for their differentiation and function. J Leukoc Biol (2013) 0.84
Differential Ly49e expression pathways in resting versus TCR-activated intraepithelial γδ T cells. J Immunol (2013) 0.83
Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors. J Leukoc Biol (2003) 0.82
Plasminogen interaction with Trypanosoma cruzi. Mem Inst Oswaldo Cruz (2004) 0.80
Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. Clin Exp Immunol (2006) 0.80
Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease. Int J Cardiol (2015) 0.79
Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response. PLoS Negl Trop Dis (2016) 0.76